Wharton’ jelly mesenchymal stromal cell therapy for ischemic brain injury

Increasing evidence have supported that Wharton's jelly mesenchymal stem cell (WJ-MSCs) have immunomodulatory and protective effects against several diseases including kidney, liver pathologies, and heart injury. Few in vitro studies have reported that WJ-MSCs reduced inflammation in hippocampa...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Kuo-Jen, Yu, Seong-Jin, Chiang, Chia-Wen, Lee, Yu-Wei, Yen, B. Linju, Hsu, Chun-Sen, Kuo, Li-Wei, Wang, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6187942/
https://www.ncbi.nlm.nih.gov/pubmed/30450419
http://dx.doi.org/10.4103/bc.bc_16_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6187942/
https://www.ncbi.nlm.nih.gov/pubmed/30450419
http://dx.doi.org/10.4103/bc.bc_16_18

Ejemplares similares